Skip to main content
Signal8

Odrich Marc

SEC insider (Form 3/4/5 filer). CIK 0002015900. Chief Medical Officer at LENZ Therapeutics, Inc. (LENZ). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in SOLANA BEACH, CA.

Companies Odrich Marc has filed insider reports for

  • LENZ Therapeutics, Inc. (LENZ): Officer, Chief Medical Officer
Odrich Marc profile photo

Odrich Marc

CIK: 0002015900

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LENZ Therapeutics, Inc. logo
LENZ

LENZ Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • LENZ Therapeutics, Inc. logo
    LENZ

    LENZ Therapeutics, Inc.

    Jan 2, 2026
    Award

    Stock Option (right to buy)

    Direct
    84.2K shares-
  • LENZ Therapeutics, Inc. logo
    LENZ

    LENZ Therapeutics, Inc.

    Jan 2, 2026
    Award

    Restricted Stock Unit

    Direct
    14K shares-
  • LENZ Therapeutics, Inc. logo
    LENZ

    LENZ Therapeutics, Inc.

    Jan 9, 2025
    Award

    Stock Option (right to buy)

    Direct
    80.1K shares-

1-3 of 3